- 7357-41-7Benzenesulfonylchloride, 3,3'-sulfonylbis-
- 7357-42-8Formamide,N-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-
- 73575-52-71,1'-Biphenyl,2,3',4,5'-tetrachloro-
- 73575-55-01,1'-Biphenyl,2,2',3,5,6'-pentachloro-
- 7357-56-4Decanoic acid,2-bromo-, methyl ester
- 73576-32-64(3H)-Pyrimidinone, 2-amino-6-(1-methylethyl)-
- 73576-33-72-Pyrimidinamine,4-chloro-6-(1-methylethyl)-
- 7357-67-7N-(3-Chloropropyl)morpholine
- 7357-70-22-Cyanothioacetamide
- 7357-74-62-(carbamoylamino)-2-methyl-nonanoic acid
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Mevastatin |
EINECS | 700-442-0 |
| CAS No. | 73573-88-3 | Density | 1.13 g/cm3 |
| PSA | 72.83000 | LogP | 3.94950 |
| Solubility | DMSO: 20 mg/mL | Melting Point |
151-153 °C |
| Formula | C23H34O5 | Boiling Point | 555 °C at 760 mmHg |
| Molecular Weight | 390.52 | Flash Point | 186.5 °C |
| Transport Information | N/A | Appearance | off-white solid |
| Safety | 22-24/25-45-36/37/39 | Risk Codes | 26/27/28 |
| Molecular Structure |
|
Hazard Symbols |
 T+
|
| Synonyms |
Butanoicacid, 2-methyl-,(1S,7S,8S,8αR)-1,2,3,7,8,8α-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenylester, (2S)-;Butanoicacid, 2-methyl-,1,2,3,7,8,8α-hexahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenylester, [1S-[1α(R*),7b,8b(2S*,4S*),8ab]]-;Antibiotic ML 236B;CS 500;CS 500(antibiotic);Compactin;Compactin (Penicillium);L 637312;ML 236B;ML 236Blactone;NSC 281245;Statin I; |
Article Data | 18 |
Mevastatin Synthetic route
- 79814-60-1
(1S,2S,8S,8aR,3'R,5'R,2''S)-methyl 1,2,6,7,8,8a-hexahydro-3',5'-dihydroxy-2-methyl-8-<(2-methyl-1-oxobutyl)oxy>-1-naphthaleneheptanoate
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With toluene-4-sulfonic acid In benzene for 1.08333h; Ambient temperature; | 70% |
| With toluene-4-sulfonic acid In benzene | 70% |
- 116996-42-0, 117065-49-3
(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R)-4,6-dihydroxy-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With Celite; silver carbonate In toluene at 95℃; for 2h; | 61% |
- 84751-53-1
(1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-<2-((2R,4R)-tetrahydro-4-methoxy-6-oxo-2H-pyran-2-yl)-ethyl>-1-naphthyl (2S)-2-methylbutyrate
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With boron tribromide In dichloromethane at -23℃; for 5h; | 31% |
| With boron tribromide In dichloromethane at -23℃; for 6h; | 31% |
- 108713-03-7
(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-(tert-butyl-diphenyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With hydrogen fluoride In water; acetonitrile at 45℃; for 8h; | 30% |
- 87000-71-3
(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With hydrogen fluoride In acetonitrile at 25℃; for 0.5h; Yield given; |
- 116996-42-0, 117065-49-3
(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R,6S)-4,6-dihydroxy-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With Celite; silver carbonate In toluene at 95℃; for 2h; Yield given; |
- 67383-81-7, 79814-60-1, 79896-19-8, 79896-20-1, 79896-21-2, 109785-25-3, 109785-26-4
3,5-Dihydroxy-7-[(1S,2S,8S,8aR)-2-methyl-8-((S)-2-methyl-butyryloxy)-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl]-heptanoic acid methyl ester
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| With toluene-4-sulfonic acid In benzene at 25℃; for 0.5h; |
- 67383-81-7, 79814-60-1, 79896-19-8, 79896-20-1, 79896-21-2, 109785-25-3, 109785-26-4
(R)-3,5-Dihydroxy-7-[(1S,2S,8S,8aR)-2-methyl-8-((S)-2-methyl-butyryloxy)-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl]-heptanoic acid methyl ester
A
- 73573-88-3
mevastatin
B
- 84173-31-9
3,5-bis-epi-compactin
| Conditions | Yield |
|---|---|
| With toluene-4-sulfonic acid In benzene at 25℃; for 0.25h; | A 32 mg B 22 mg |
- 67383-81-7, 79814-60-1, 79896-19-8, 79896-20-1, 79896-21-2, 109785-25-3, 109785-26-4
methyl 3,5-dihydroxy-7-<(1'S,2'S,8'S,8a'S)-2'methyl-8'-<(S)-2-methylbutanoyloxy>-1',2',3',7',8',8a'-hexahydro-1'-naphthyl>heptanoate
A
- 73573-88-3
mevastatin
B
- 84173-31-9
3,5-bis-epi-compactin
| Conditions | Yield |
|---|---|
| With pyridine hydrogenfluoride In acetonitrile at 0℃; for 6h; | A 15.6 mg B 15.4 mg |
- 116996-36-2, 117065-47-1
(4S,6R)-4-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-2,2-dimethyl-6-[2-((1S,2S,8aR)-2-methyl-8-triethylsilanyloxy-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl)-ethyl]-[1,3]dioxane
- 73573-88-3
mevastatin
| Conditions | Yield |
|---|---|
| Multi-step reaction with 8 steps 1: 1.) HF; 2.) 2-methoxypropene / 2.) pyridinium p-toluenesulfonate / 1.) H2O, MeCN, r.t., 1.75 h; 2.) CH2Cl2, 0 deg C, 40 min 2: 1.) (COCl)2; 2.Et3N / 1.) DMSO, CH2Cl2, -78 deg C, 15 min; 2.) -78 deg C, 5 min 3: 80 percent / L-Selectride / tetrahydrofuran / -78 deg C, 1 h; -43 deg C, 12 h 4: 99 percent / Et3N / DMAP / CH2Cl2 / 68 h / Ambient temperature 5: 92 percent / Bu4NF / tetrahydrofuran / 1.75 h / Ambient temperature 6: 1.) (COCl)2; 2.) Et3N / 1.) DMSO,CH2Cl2, -78 deg C, 20 min; 2.) -78 deg C, 10 min, -78 deg C -> r.t., 30 min 7: 88 percent / 1.3N HCl / tetrahydrofuran / 2 h / Ambient temperature 8: 61 percent / Ag2CO3/Celite / toluene / 2 h / 95 °C View Scheme | |
| Multi-step reaction with 8 steps 1: 1.) 48percent aq. HF, 2.) 2-methoxypropene, pyridinium p-toluenesulfonate / 1.) MeCN, RT, 1.75 h, 2.) CH2Cl2, 0 deg C, 40 min 2: 93 percent / (COCl)2, DMSO / CH2Cl2 / 0.25 h / -78 °C 3: 80 percent / L-Selectride / tetrahydrofuran / 1.) -78 deg C, 1 h, 2.) -43 deg C, 12 h 4: 99 percent / Et3N, 4-(dimethylamino)pyridine (DMAP) / CH2Cl2 / 68 h / Ambient temperature 5: 92 percent / Bu4N(1+)*F(1-) / tetrahydrofuran / 1.75 h / Ambient temperature 6: 91 percent / (COCl)2, DMSO / CH2Cl2 / 0.33 h / -78 °C 7: 88 percent / 10percent aq. HCl / tetrahydrofuran / 2 h / Ambient temperature 8: 61 percent / Ag2CO3/Celite / toluene / 2 h / 95 °C View Scheme |
Mevastatin History
Mevastatin Specification
The IUPAC name of Mevastatin is [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate. With the CAS registry number 73573-88-3, it is also named as Compactin. The product's categories are Active Pharmaceutical Ingredients; Various Metabolites and Impurities; Metabolites; Pharmaceuticals; HMG-CoA Reductase, and the other registry numbers are 58948-09-7; 60478-65-1. Besides, it is off-white solid, which should be stored in sealed containers in a cool, dry place at 2-8 °C away from oxidizing agents. In addition, its molecular formula is C23H34O5 and molecular weight is 390.52.
The other characteristics of this product can be summarized as: (1)ACD/LogP: 3.57; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.57; (4)ACD/LogD (pH 7.4): 3.57; (5)ACD/BCF (pH 5.5): 306.24; (6)ACD/BCF (pH 7.4): 306.24; (7)ACD/KOC (pH 5.5): 2094.71; (8)ACD/KOC (pH 7.4): 2094.71; (9)#H bond acceptors: 5; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 8; (12)Index of Refraction: 1.535; (13)Molar Refractivity: 107.1 cm3; (14)Molar Volume: 343.8 cm3; (15)Surface Tension: 44.5 dyne/cm; (16)Density: 1.13 g/cm3; (17)Flash Point: 186.5 °C; (18)Melting Point: 151-153 °C; (19)Solubility: DMSO: 20 mg/mL; (20)Enthalpy of Vaporization: 96.1 kJ/mol; (21)Boiling Point: 555 °C at 760 mmHg; (22)Vapour Pressure: 1.25E-14 mmHg at 25 °C.
Preparation of Mevastatin: this chemical can be prepared by 2-Methyl-butyric acid 8-[2-(4,6-dihydroxy-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester.
.jpg)
This reaction needs Ag2CO3/Celite and Toluene at temperature of 95 °C. The reaction time is 2 hours. The yield is 61 %.
Uses of Mevastatin: this chemical is a hypolipidemic agent. It is also used as a HMG-CoA reductase inhibitor. Similarly, it can be used to produce Desmethylmonacolin J.
.jpg)
This reaction needs aq. LiOH by heating for 1 day. The yield is 75 %.
When you are using this chemical, please be cautious about it as the following: it is very toxic by inhalation, in contact with skin and if swallowed. Please do not breathe dust. And you should wear suitable protective clothing, gloves and eye/face protection to avoid contact with skin and eyes. Moreover, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
People can use the following data to convert to the molecule structure.
(1)SMILES: O=C(O[C@@H]1[C@H]3C(=C/CC1)\C=C/[C@@H]([C@@H]3CC[C@H]2OC(=O)C[C@H](O)C2)C)[C@@H](C)CC
(2)InChI: InChI=1/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3/t14-,15-,17+,18+,19-,20-,22-/m0/s1
(3)InChIKey: AJLFOPYRIVGYMJ-INTXDZFKBX
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD | oral | > 2gm/kg (2000mg/kg) | Journal of Antibiotics. Vol. 29, Pg. 1346, 1976. | |
| mouse | LD50 | intraperitoneal | 500mg/kg (500mg/kg) | Journal of Antibiotics. Vol. 29, Pg. 1346, 1976. |
What can I do for you?
Get Best Price
